Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets
Links shared publicly online about this topic.
- 785total visits
Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.
View full resource at news-medical.net
Tags: Parkinson's Disease, Parkinson's Disease Medication, Neuropathic Pain Medication, Disease and Condition, FDA, Sifrol, Mirapex, disease
Most Recently Shared on October 21, 2010 at 4:13 pm By:
Parkinson's Disease: Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets: Mylan Inc. today a... http://bit.ly/azUuAK
Advertisement
